The founder and principal advisor of Red Maple Consulting, brings unparalleled expertise and a proven track record to deliver high-impact strategies. His qualifications are rooted in three core strengths:

• With over 25 years in diagnostics, pharmaceuticals, and precision medicine at Ventana, Roche, and Genentech, Kevin has driven innovation in oncology. His global experience includes a five-year assignment in Switzerland, where he developed strategies for instruments, assays, and software solutions, scaling a $700M immunoassay portfolio at Roche Diagnostics. This deep industry knowledge ensures tailored, cutting-edge solutions for biotech challenges.

• As Head of the Biomarker Testing Team at Genentech, Kevin led a 30+ person commercial team to enhance guideline-based companion diagnostic testing, enabling patents to access targeted therapies through improved testing rates and accessibility. He has also spearheaded U.S. sales and marketing organizations to achieve market expansion, demonstrating his ability to lead complex teams and drive commercial success.

• As the founder of Red Maple Consulting, Kevin provides strategic consulting services to biotech companies and venture capital firms, leveraging his extensive experience to advance access, education, and differentiation. His work focuses on delivering actionable strategies that align with client goals, making him an ideal partner to support your business.